T Rowe Price

    By Rick Aristotle Munarriz, The Motley Fool

    | 1:50PM 10/07/2011
    Facebook will go public someday, but not anytime soon: The IPO market has all but dried up, and flush Facebook doesn't need the cash. Thankfully, there are plenty of other means of investing in social networking. Let's go over five ways to play this phenomenon right now.

    By Rick Aristotle Munarriz, The Motley Fool

    | 4:15PM 7/22/2011
    There's no such thing as a summertime lull when earnings season is upon us. Even if you don't feel like alerting the "sell in May and go away" camp of investors, there are plenty of headlines to be written about. Here are five things that will shape the way the market acts in the week ahead.

    By Sheryl Nance-Nash

    | 6:30AM 5/18/2011
    It's more than a question of "Do I have enough money?" Practicing retirement is a way to dip your toe into the post-work waters and see if they're too hot, too cold, too "just not you yet," or just right. Are you really ready financially -- and emotionally? Here's how to find out.

    By The Motley Fool

    | 5:00PM 4/05/2011
    When will Groupon and Living Social go public...and how have the sites already changed the way older companies do business? With high profit margins leading to steep valuation, it looks like the group coupon market is poised to explode!

    By Sheryl Nance-Nash

    | 7:20PM 12/28/2009
    Providers of exchange-traded funds and notes had a strong 2009 and the new year is shaping up to bring more of the same. But what's good for ETF companies isn't necessarily good for investors.

    By Matthew Scott

    | 12:00PM 12/27/2009
    If the health care bills in Congress become law, the biotech sector may become one of the biggest beneficiaries. Here are six stocks and mutual funds that stand to gain the most from the changes.